StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
LLYBullishEarningsnews
High materiality8/10

Eli Lilly lifts 2026 guidance on robust Q2, pipeline momentum and manufacturing expansion

Aug 5, 2026, 6:47 AM EDT3 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The beat-and-raise earnings narrative, combined with expanding Mounjaro/Zepbound franchises and multiple regulatory milestones, typically prompts short-term upside. However, elevated IPR&D charges temper GAAP earnings, so the upside may be moderated by profit-quality concerns and optics around acquisitions. Historically, Lilly has shown stock moves on strong guidance and pipeline news, supporting a near-term rally.

AI summary

What happened, with direct paths to the underlying reporting

Eli Lilly delivered a strong Q2 2026, with revenue of $23.0B (+48% YoY) driven by Mounjaro and Zepbound, and both GAAP and non-GAAP EPS beating prior guidance. The company raised 2026 revenue guidance to $85–$87B and non-GAAP EPS to $35.50–$36.50, partially offset by $3.03B in acquired IPR&D charges. Regulatory and pipeline progress, plus aggressive manufacturing expansion, position Lilly for continued growth into 2027.

  • Q2 2026 revenue $23.0B, up 48% YoY, led by Mounjaro/Zepbound.
  • GAAP EPS $7.94; non-GAAP EPS $8.38; includes $3.03B acquired IPR&D charges.
  • 2026 revenue guidance raised to $85–$87B; non-GAAP EPS $35.50–$36.50.
  • Regulatory progress: CHMP recommends Jaypirca; FDA approves EBGLYSS (lebrikizumab) for AD.
  • Mounjaro $9.9B globally; Zepbound US $4.9B; Indiana capex $4.5B expansion.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event